Research ArticleOriginal Article
A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer
Xu Zhang, Na Qin, Jingyi Fan, Chang Zhang, Qi Sun, Yayun Gu, Meng Zhu, Erbao Zhang, Juncheng Dai, Guangfu Jin, Hongxia Ma, Zhibin Hu and Hongbing Shen
Cancer Biology & Medicine September 2022, 19 (9) 1385-1396; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0068
Xu Zhang
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
Na Qin
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Jingyi Fan
3Health Management Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215008, China
Chang Zhang
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
Qi Sun
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
Yayun Gu
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Meng Zhu
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Erbao Zhang
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Juncheng Dai
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Guangfu Jin
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Hongxia Ma
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
4Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing 100730, China
Zhibin Hu
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Hongbing Shen
1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
4Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing 100730, China
References
- 1.↵
- 2.
- Zhao M,
- Feng J,
- Tang L.
- 3.↵
- Chen X,
- Shen C,
- Wei Z,
- Zhang R,
- Wang Y,
- Jiang L, et al.
- 4.↵
- 5.↵
- Moreno-Rubio J,
- Ponce S,
- Alvarez R,
- Olmedo ME,
- Falagan S,
- Mielgo X, et al.
- 6.↵
- Malhotra J,
- Malvezzi M,
- Negri E,
- La Vecchia C,
- Boffetta P.
- 7.↵
- Wang Y,
- Ma R,
- Liu B,
- Kong J,
- Lin H,
- Yu X, et al.
- 8.↵
- Dai J,
- Lv J,
- Zhu M,
- Wang Y,
- Qin N,
- Ma H, et al.
- 9.↵
- Dai J,
- Shen W,
- Wen W,
- Chang J,
- Wang T,
- Chen H, et al.
- 10.↵
- Bosse Y,
- Amos CI.
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- Liu B,
- Montgomery SB.
- 15.↵
- Qin N,
- Li Y,
- Wang C,
- Zhu M,
- Dai J,
- Hong T, et al.
- 16.↵
- 17.↵
- Hashemi M,
- Aftabi S,
- Moazeni-Roodi A,
- Sarani H,
- Wiechec E,
- Ghavami S.
- 18.↵
- Mandal R,
- Barron JC,
- Kostova I,
- Becker S,
- Strebhardt K.
- 19.↵
- 20.↵
- Wang HB,
- Li T,
- Ma DZ,
- Ji YX,
- Zhi H.
- 21.↵
- Tummers B,
- Mari L,
- Guy CS,
- Heckmann BL,
- Rodriguez DA,
- Ruhl S, et al.
- 22.↵
- Camp NJ,
- Lin WY,
- Bigelow A,
- Burghel GJ,
- Mosbruger TL,
- Parry MA, et al.
- 23.
- Zhao XK,
- Mao YM,
- Meng H,
- Song X,
- Hu SJ,
- Lv S, et al.
- 24.
- 25.↵
- Lin Y,
- Chahal HS,
- Wu W,
- Cho HG,
- Ransohoff KJ,
- Dai H, et al.
- 26.↵
- Petrosino M,
- Novak L,
- Pasquo A,
- Chiaraluce R,
- Turina P,
- Capriotti E, et al.
- 27.↵
- 28.↵
- Capriotti E,
- Fariselli P,
- Casadio R.
- 29.
- Zhang Z,
- Wang L,
- Gao Y,
- Zhang J,
- Zhenirovskyy M,
- Alexov E.
- 30.
- Wang Z,
- Moult J.
- 31.↵
- Yue P,
- Li Z,
- Moult J.
- 32.↵
- Singh SM,
- Bandi S,
- Shah DD,
- Armstrong G,
- Mallela KM.
- 33.↵
- Liao CY,
- Yang SF,
- Wu TJ,
- Chang H,
- Huang CF,
- Liu YF, et al.
- 34.↵
- 35.↵
- Mondal S,
- Adhikari N,
- Banerjee S,
- Amin SA,
- Jha T.
- 36.↵
- Chen Q,
- Huang X,
- Dong X,
- Wu J,
- Teng F,
- Xu H.
- 37.↵
- Jensen K,
- WuWong DJ,
- Wong S,
- Matsuyama M,
- Matsuyama S.
- 38.
- Jiang M,
- Qi L,
- Li L,
- Li Y.
- 39.↵
- Ruvolo PP,
- Deng X,
- May WS.
- 40.↵
- Hengartner MO.
- 41.↵
- 42.↵
In this issue
A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer
Xu Zhang, Na Qin, Jingyi Fan, Chang Zhang, Qi Sun, Yayun Gu, Meng Zhu, Erbao Zhang, Juncheng Dai, Guangfu Jin, Hongxia Ma, Zhibin Hu, Hongbing Shen
Cancer Biology & Medicine Sep 2022, 19 (9) 1385-1396; DOI: 10.20892/j.issn.2095-3941.2022.0068
A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer
Xu Zhang, Na Qin, Jingyi Fan, Chang Zhang, Qi Sun, Yayun Gu, Meng Zhu, Erbao Zhang, Juncheng Dai, Guangfu Jin, Hongxia Ma, Zhibin Hu, Hongbing Shen
Cancer Biology & Medicine Sep 2022, 19 (9) 1385-1396; DOI: 10.20892/j.issn.2095-3941.2022.0068
Jump to section
Related Articles
- No related articles found.